Platinum sensitivity and non-cross-resistance of cisplatin analogue with cisplatin in recurrent cervical cancer.

However, both of these factors did not reach statistical significance in multivariate analysis for the association with the rate of response to second-line chemotherapy (p=0.055 and p=0.057, respectively) ( Table 2 ). 3.

also in 111,027 other papers